[Featured Stock] Selvas Healthcare Benefits from Government Medical Device Policy... Selvas AI and Polaris Office Also Rise
Selvas Healthcare is showing strong performance. It is interpreted that the government's medical device industry promotion policy is having a positive impact on the stock price.
As of 9:26 AM on the 24th, Selvas Healthcare is trading at 12,900 KRW, up 6% from the previous day. Its parent company Selvas AI and the second largest shareholder Polaris Office are also showing strong gains. Selvas AI is trading at 35,100 KRW, up 1.3% from the previous day, and Polaris Office is trading at 2,970 KRW, up 1.02%.
Selvas Healthcare is a smart healthcare specialized company that has developed body composition analyzers and fully automatic blood pressure monitors. It operates the medical diagnostic device brand ACCUNIQ and the assistive technology device brand for the visually impaired, HIMS. It is actively expanding its AI medical device business by applying the AI voice recognition technology of its parent company Selvas AI to medical devices.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Selvas AI and Polaris Office are collaborating on the development of an AI office using AI voice recognition technology. Polaris Office is currently preparing an AI office applying various artificial intelligence models.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
